OKYO Pharma Limited (OKYO) Stock Overview
Explore OKYO Pharma Limited’s financial performance, market position, analyst ratings, and future outlook.
OKYO Pharma Limited (OKYO)
Key Financials
Key Financials
Market Cap
58.3M
P/E Ratio
-12.49
EPS (TTM)
$-0.11
ROE
1.03%
OKYO Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of OKYO Pharma Limited (OKYO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 40.71, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $2.92.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -12.49 and a market capitalization of 58.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.